Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEquals Gp Regulatory News (EQLS)

Share Price Information for Equals Gp (EQLS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.885%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 113.50
EQLS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Review Update and PUSU Extension

17 Apr 2024 07:00

RNS Number : 8405K
Equals Group PLC
17 April 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MIGHT BE MADE.

FOR IMMEDIATE RELEASE 17 April 2024

Equals Group plc

("Equals", the "Group" or the "Company")

 

Strategic Review Update and extension of PUSU Deadline

Strategic Review Update

On 1 November 2023 the Board of Equals announced that it is conducting a review of the Company's strategic options (the "Strategic Review") and that as part of this process, the Company has contacted a limited number of potential counterparties including Madison Dearborn Partners, LLC ("MDP"), to assess whether such parties could put forward a proposal that would deliver greater value to Equals' shareholders than pursuing a standalone independent strategy (the "Strategic Review").

The Board also noted in its announcement of 1 November 2023 that any such proposal could include an offer for the entire issued and to be issued share capital of the Company and as such the effect of the announcement was to commence an 'offer period' in respect of the Company in accordance with the Takeover Code (the "Code").

On 20 March 2024 Equals announced it had received an indicative non-binding proposal from a consortium (the "Consortium") comprising Embedded Finance Limited ("Railsr") and TowerBrook Capital Partners (U.K.) LLP ("Towerbrook") regarding a possible offer for the entire issued and to be issued share capital of Equals.

Whilst the Board recognises the time elapsed since the commencement of the Strategic Review, having now received indicative non-binding proposals from both MDP and the Consortium, it considers it to be in the best interests of shareholders that the Strategic Review remains ongoing to allow further time for it to reach its conclusion.

PUSU Extension

The announcement of 1 November 2023 stated that, in accordance with Rule 2.6(a) of the Code, by not later than 5.00 pm on 29 November 2023, MDP must either announce a firm intention to make an offer for Equals under Rule 2.7 of the Takeover Code or announce that it does not intend to make an offer for Equals, in which case the announcement will be treated as a statement to which Rule 2.8 of the Takeover Code applies (the "PUSU Deadline"). That deadline was subsequently extended on a number of occasions, most recently to 5.00 pm on 17 April 2024, as announced on 20 March 2024.

The announcement of 20 March 2024 regarding the Consortium stated similarly that, in accordance with Rule 2.6(a) of the Code, by not later than 5.00 pm on 17 April 2024, the Consortium must either announce a firm intention to make an offer for Equals under Rule 2.7 of the Takeover Code or announce that it does not intend to make an offer for Equals, in which case the announcement will be treated as a statement to which Rule 2.8 of the Takeover Code applies.

Accordingly, the revised PUSU Deadline is the same for both of MDP and the Consortium.

As part of the Strategic Review, discussions and due diligence are ongoing between Equals and each of MDP and the Consortium and, to allow further time for these discussions and due diligence to take place, the Board of Equals has requested that the Panel on Takeovers and Mergers (the "Panel") extends the PUSU Deadline further.

In the light of this request, an extension has been granted by the Panel and, in accordance with Rule 2.6(a) of the Code, each of MDP and the Consortium are required, by not later than 5.00 pm on 15 May 2024, either to announce a firm intention to make an offer in accordance with Rule 2.7 of the Code or to announce that they do not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This revised PUSU Deadline may be extended with the consent of the Panel, at Equals' request, in accordance with Rule 2.6(c) of the Code.

There can be no certainty either that an offer will be made nor as to the terms of any offer, if made.

A further announcement will be made when appropriate.

For more information, please contact:

 

Equals +44 (0) 20 7778 9308Ian Strafford-Taylor / Richard Cooper

 

Canaccord Genuity (Financial Adviser to Equals) +44 (0) 20 7523 8000

Sunil Duggal / Bill Gardiner

 

Lazard (Financial Adviser to Equals) +44 (0) 20 7187 2000

Nicholas Millar / Jason Welham

 

Canaccord Genuity (Nominated Adviser & Sole Broker to Equals) +44 (0) 20 7523 8000

Max Hartley / Harry Rees

Buchanan (Financial Communications for Equals) +44 (0) 20 7466 5000

Henry Harrison-Topham / Toto Berger / Stephanie Whitmore

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAALKFFELEFA
Date   Source Headline
8th Dec 20217:00 amRNSTrading Update
28th Oct 20217:00 amRNSMaterial transaction
25th Oct 20217:00 amRNSNotification of Major Holdings
18th Oct 20217:00 amRNSDiscretionary Share Incentive Plan & 2021 Awards
15th Oct 20219:03 amRNSAIM Rule 17 Schedule 2(g) Update
11th Oct 20217:00 amRNSTrading Update
22nd Sep 20217:00 amRNSNotification of Major Holdings
16th Sep 20212:03 pmRNSExercise of share Options and Issue of Equity
14th Sep 20217:00 amRNSInterim Results
13th Sep 20217:00 amRNSPresentation via Investor Meet Company
12th Aug 20217:00 amRNSNotice of Interim Results
16th Jul 20217:00 amRNSExercise of Share Options and Issue of Equity
15th Jul 202112:15 pmRNSDirector/PDMR Shareholding
12th Jul 20217:00 amRNSDirector/PDMR Shareholding
8th Jul 20217:00 amRNSH1-2021 Trading Update
10th Jun 202112:30 pmRNSResult of Annual General Meeting
17th May 20215:31 pmRNSNotice of Annual General Meeting
11th May 20215:40 pmRNSNotification of Major Holdings
6th May 20217:00 amRNSCapital Markets Day
5th May 202111:25 amRNSDirector Dealing
28th Apr 20214:15 pmRNSPublication of Annual Report & Accounts
19th Apr 20213:54 pmRNSExercise of Share Options and Issue of Equity
14th Apr 20217:00 amRNSNotification of Major Holdings
14th Apr 20217:00 amRNSPresentation via Investor Meet Company
9th Apr 20217:00 amRNSAppointment of Independent Non-Executive Director
8th Apr 20217:00 amRNSNotice of Capital Markets Day
8th Apr 20217:00 amRNSFinal Results
1st Apr 20217:00 amRNSEquals joins anti-fraud scheme
29th Mar 20217:00 amRNSNotice of Final Results
26th Mar 20217:00 amRNSChange of Adviser
25th Mar 20217:00 amRNSLaunch of B2C Linked Cards
1st Mar 20217:00 amRNSPartnership with Tap Global
15th Jan 20211:09 pmRNSNotification of Major Holdings
15th Jan 202112:51 pmRNSNotification of Major Holdings
6th Jan 20219:05 amRNSSecond Price Monitoring Extn
6th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSFY-2020 Trading Update
3rd Dec 202011:30 amRNSDirector Dealing
1st Dec 20207:00 amRNSTrading Update
11th Nov 20201:00 pmRNSDirectors Shareholdings
10th Nov 20207:00 amRNSB2B Payments agreement with HomeSend
20th Oct 20206:01 pmRNSNOTIFICATION OF MAJOR HOLDINGS
15th Oct 20207:00 amRNSAcquisition and further B2B growth initiatives
12th Oct 20204:41 pmRNSNotification of Major Holdings
8th Oct 20207:00 amRNSDirectorate Change
6th Oct 20205:11 pmRNSNotification of Major Holdings
1st Oct 202012:00 pmRNSAppointment of Independent Non-Executive Director
23rd Sep 20207:00 amRNSInterim Results
15th Sep 20207:00 amRNSDirectorate Changes
4th Sep 20207:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.